XOMA Corp logo Shares of XOMA Corp (NASDAQ:XOMA) have received an average rating of “Hold” from the ten analysts that are presently covering the company, American Banking News. XOMA Corp (NASDAQ:XOMA) shares after opening at $5.20 moved to $5.54 on last trade day and at the end of the day closed at $5.27. Company price to sales ratio in past twelve months was calculated as 15.82 and price to cash ratio as 4.61. XOMA Corp (NASDAQ:XOMA) showed a negative weekly performance of -2.41%.
Pharmacyclics, Inc. (NASDAQ:PCYC) on 27 march announced that a former employee filed a complaint against the Company in Superior Court of Santa Clara, California. Pharmacyclics, Inc. (NASDAQ:PCYC) shares advanced 7.18% in last trading session and ended the day on $107.42. PCYC return on equity ratio is recorded as 13.00% and its return on assets is 10.60%. Pharmacyclics, Inc. (NASDAQ:PCYC) yearly performance is 34.75%.
On March 18, 2014, Unilife Corporation’s (NASDAQ:UNIS) Chief Financial Officer and Executive Vice President, R. Richard Wieland II, entered into a Separation Agreement and General Release (the “Separation Agreement”) with the Company. Mr. Wieland’s last day of employment with the Company was March 12, 2014. Unilife Corp (NASDAQ:UNIS) shares moved down -5.41% in last trading session and was closed at $3.85, while trading in range of $3.83 – $4.23. Unilife Corp (NASDAQ:UNIS) year to date (YTD) performance is -12.50%.
Theravance, Inc. (NASDAQ: THRX) announced yesterday the appointment of Kevin Kwok as Head of Talent Acquisition and Strategy. Theravance Inc. (NASDAQ:THRX) weekly performance is 0.55%. On last trading day company shares ended up $31.33. Theravance Inc. (NASDAQ:THRX) distance from 50-day simple moving average (SMA50) is -13.23%. Analysts mean target price for the company is $42.00.